Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
INVO Fertility, Inc. incurred loan of $1,500,000 with Decathlon Alpha V LP at based on a minimum amount that increases from thirty five percent (35%) of the L maturing June 29, 2028.
- Instrument
- loan
- Principal
- $1,500,000
- Counterparty
- Decathlon Alpha V LP
- Rate
- based on a minimum amount that increases from thirty five percent (35%) of the L
- Maturity
- June 29, 2028
- Event
- incurrence
Exact text from the filing
under which the Lender made a revenue loan advance in the gross amount of $1,500,000
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
INVO Fertility, Inc. entered into Revenue Loan and Security Agreement with Decathlon Alpha V LP valued at $1,500,000 (effective 2023-09-29).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- Decathlon Alpha V LP
- Value
- $1,500,000
- Effective
- 2023-09-29
Exact text from the filing
On September 29, 2023, INVO Bioscience, Inc. (the “Company”), Steven Shum, as a Key Person, and the Company’s wholly-owned subsidiaries Bio X Cell, Inc, INVO Centers, LLC, Wood Violet Fertility LLC, Fertility Labs of Wisconsin LLC and Orange Blossom Fertility LLC as guarantors (the “Guarantors”), entered into a Revenue Loan and Security Agreement (the “Loan Agreement”) with Decathlon Alpha V LP (the “Lender”) under which the Lender made a revenue loan advance in the gross amount of $1,500,000 (the “Loan”).
View on SEC.gov